PROVIDER PROFILE · NPI 1891880563

Massimo CristofanilliM.D.

Medical OncologyNew York, NYI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

146

Unique beneficiaries

—

Total services

561

Distinct HCPCS

Medicare payment

$66K

Peer benchmark

Total Medicare services vs. 506 Medical Oncology providers in NY — above median (cohort median 458).

PRESCRIBING · PART D · 2024

Total Rx claims

Beneficiaries

—

Total drug cost

$139

Distinct drugs

Brand share

0.0%

Top prescribed drugs

Anastrozole12 claims

QUALITY · MIPS · 2024

Final MIPS score

100.0

Quality

85.3

Cost

0.0

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

1.05%

APM Entity

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$46K

Payment records

By payment type

Consulting Fee$25K

Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$19K

Travel and Lodging$1K

Food and Beverage$516

REFERRAL NETWORK

Where Massimo Cristofanilli's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 5 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
THOMAS JEFFERSON UNIVERSITY HOSPITALS INC	50	766
UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER	24	116
SANTARSIERO, ELIZABETH	23	68
Adam Berger Surgical Oncology · New Brunswick, NJ	15	100
KIM, SUNG	14	73

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history